SHORT TITLE; FINDING.

SEC. 2311. SHORT TITLE; FINDING. (a) [21 U.S.C. 301 note] Short Title.—This chapter may be cited as the “Animal Generic Drug User Fee Amendments of 2023”. (b) [21 U.S.C. 379j-21 note] Finding.—Congress finds that the fees authorized by the amendments made in this chapter will be dedicated toward expediting the generic new animal drug development process and the review of abbreviated applications for generic new animal drugs, supplemental abbreviated applications for generic new animal drugs, and investigational submissions for generic new animal drugs as set forth in the goals identified for purposes of part 5 of subchapter C of chapter VII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j-21 et seq.), in the letters from the Secretary of Health and Human Services to the Chairman of the Committee on Energy and Commerce of the House of Representatives and the Chairman of the Committee on Health, Education, Labor, and Pensions of the Senate as set forth in the Congressional Record.